European Cardiac Patient Monitoring Market Expected to Reach $583.6 Million by 2016

Frost & Sullivan's (San Antonio, TX, USA) new market analysis, “European Cardiac Patient Monitoring Solutions Outlook,” reports that the European market for cardiac patient monitoring earned $389.3 million in 2009 and forecasts this to reach $583.6 million in 2016. The major factor driving market growth is the demand for patient-friendly, easy-to-use devices that enable effective diagnoses of cardiovascular diseases. Other contributing factors cited are the increase in unhealthy lifestyles and the rise in cardiovascular diseases.

The cardiac patient monitoring market is expanding with the development of innovative, advanced software applications that facilitate the diagnoses of heart conditions. There is also increased demand for monitoring systems with better connectivity, flexibility, and networking capabilities and improve integration.

The challenge to this market is the absence of a consistent reimbursement policy throughout Europe. For example, private hospitals and clinics are experiencing a decrease in patient intake due to the lack of adequate reimbursement.

"Competition has intensified as the market for cardiac patient monitoring becomes progressively more saturated," warns Frost & Sullivan Senior Research Analyst Akanksha Joshi. "Brand loyalty and stagnation on the technological front have created difficulties for new entrants, while reducing profit margins for established companies."

"It is important for manufacturers to provide innovative, accurate, and reliable patient-friendly devices," concludes Joshi. "This approach would invoke the medical community's interest and push replacement sales."

Related Links:
Frost & Sullivan